Calvin Sternick

Stock Analyst at JP Morgan

(1.90)
# 3,144
Out of 5,180 analysts
19
Total ratings
38.46%
Success rate
6.19%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $74.75
Upside: +47.16%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $32.00
Upside: +150.00%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $30.59
Upside: -11.74%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $184.04
Upside: -1.11%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $191.86
Upside: -57.78%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $134.03
Upside: +192.47%